Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celgene Corp (NASDAQ:CELG)

133.68
Delayed Data
As of Jun 22
 +0.85 / +0.64%
Today’s Change
94.42
Today|||52-Week Range
135.18
+15.49%
Year-to-Date
Biotech Stocks Finally Stage Breakthrough
Jun 22 / TheStreet.com - Paid Partner Content
Biotech Stock Roundup: Clovis Soars on Rubraca Data, Seattle Hit by Study Halt
Jun 21 / Zacks.com - Paid Partner Content
The Market Advance Narrows
Jun 22 / TheStreet.com - Paid Partner Content
Celgene Presents Interim Results from Cancer Drug Study
Jun 19 / Zacks.com - Paid Partner Content
Cramer: This Is No Country for Old Value
Jun 21 / TheStreet.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Apple, Procter & Gamble, Celgene, PayPal and South...
Jun 19 / Zacks.com - Paid Partner Content
Celgene Heading for All-Time High
Jun 21 / TheStreet.com - Paid Partner Content
J&J Immunotherapy Darzalex Ok'd for Expanded Combination Use
Jun 19 / Zacks.com - Paid Partner Content
Small Cancer Biotech Space in Focus, 3 Stocks Up 100% & More
Jun 21 / Zacks.com - Paid Partner Content
Celgene Bucks Biotech Trend
Jun 16 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close132.83
Today’s open133.00
Day’s range132.83 - 135.18
Volume8,887,659
Average volume (3 months)3,883,115
Market cap$103.7B
Dividend yield--
Data as of 06/22/2017

Growth & Valuation

Earnings growth (last year)+28.35%
Earnings growth (this year)+22.68%
Earnings growth (next 5 years)+20.02%
Revenue growth (last year)+22.70%
P/E ratio50.3
Price/Sales8.51
Price/Book15.67

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline+0.54+1.24%
ABBVAbbVie+1.84+2.58%
BMYBristol-Myers Squibb+1.26+2.25%
LLYEli Lilly and Co+1.67+2.02%
Data as of 06/22/2017

Financials

Next reporting dateJuly 27, 2017
EPS forecast (this quarter)$1.78
Annual revenue (last year)$10.9B
Annual profit (last year)$2.0B
Net profit margin18.30%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mark J. Alles
President &
Chief Operating Officer
Scott Andrew Smith
Corporate headquarters
Summit, New Jersey

Forecasts